# A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects

> **NCT00449709** · PHASE1 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 36 (estimated)

## Conditions studied

- Obstetric Labour, Premature
- Premature Ejaculation

## Interventions

- **DRUG:** GSK221149

## Key facts

- **NCT ID:** NCT00449709
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2012-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449709, "A Study To Assess The Pharmacokinetics Of Different Modified Release Formulations Of GSK221149 In Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00449709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*